FENOFIBRATE 67/200/267 MG CAPSULE

FENOFIBRATE 67/200/267 MG CAPSULE
Product Description

UNIQUE SELLING POINT:

  • Micronized formulation results improving patient’s compliance, daily dose reduction whilst ensuring an optimal drug efficacy.
  • Fenofibrate is a third generation fibric acid practically insoluble in water, making it challenging to consistently achieve therapeutic levels. 
  • Micronization technology dramatically improves the dissolution rate-limited gastrointestinal absorption.
  • Fenofibrate activates peroxisome proliferator activated receptor type alpha (PPARa) that increases the lipolysis and elimination of atherogenic particles. 


Read more Show less

Athena

  • IN
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Excipients Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
View company profile
Categories
more categories Show less
Specifications
  • Details
    Strenght:50.25mg/0.5mg/1mg/2mg
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
  • Measured In
    milligram
More specifications Fewer specifications
Sales Markets
Show more Show less

Athena

  • IN
  • 2015
    On CPHI since
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Excipients Manufacturer
Finished Formulation products Distributor/Buyer
Ingredients Distributor/Buyer
View company profile

More Products from Athena (2)

  • DONEPEZIL 5/10 mg ORO DISPERSIBLE TABLET

    Product DONEPEZIL 5/10 mg ORO DISPERSIBLE TABLET

    UNIQUE SELLING POINT:
    • Donepezil Oro-Dispersible Tablet is pleasant and convenient as a tablet that melts in the mouth and can be administered anytime anywhere with or without water. • Unique technology of Athena is an ideal choice for patients with Alzheimer’s disease(AD). • Significant imp...
  • DOMPERIDONE 10 mg ORO-DISPERSIBLE TABLET

    Product DOMPERIDONE 10 mg ORO-DISPERSIBLE TABLET

    UNIQUE SELLING POINT: • Firstline treatment of nausea and vomiting acting with lower potential to induce dystonic, extrapyramidal symptoms or galactorrhoea. • Orodispersible tablet formulation facilitating water-free intake by oral route in patients suffering from nausea and vomiting or who have difficult...

Athena resources (2)

  • Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai

    News Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai

    Inauguration of new R&D facility in Mumbai, India by Mr. Jean-Marc Séré-Charlet, Consul General of France- Mumbai
    22 Oct 2022
  • LEAD DOSSIERS FOR L IC ENS ING

    Brochure LEAD DOSSIERS FOR L IC ENS ING

    CARDIO AND METABOLISM

    •Bisoprolol Aspirin 5 -10/75-100 mg Capsule - EU

    • Fenofibrate 160/200/267 mg Tablet & Capsule - EU

    PAIN

    •Paracetamol Tramado l 325/37.5 mg Table t & ODT - EU/ Brazil RESPIRATORY • Levocetirizin e 5 mg ODT - EU/ RUSSIA / Brazil

    CENTRAL NERVOUSSYSTEM

    •Etifoxine 50 mg Capsule - EU

    • Ondansetro n HCL/Base 4,8 mg ODT - EU/Canada/Brazil

    • Zolpidem 5,10 mg ODT & SL - Canada/Brazil/UE

    GASTRO INTESTINAL

    • Esomeprazol e 20, 40 mg Capsul e -EU

    • Mesalazine 1 g, 2 g Sache t - EU

    • Racecadotril 10, 30 mg Taste Masked Sachet –

     

    EU UROLOGY / GYNECOLOGY

    •Secnidazol e 2 g Taste Maske d pellets Sache t –EU

    • Metronidazole 500 mg Tablet - EU